Moderna extends lipids deal to boost COVID-19 vaccine output

Moderna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet increasing demand for the medicine, the U.S. biotech company said on Thursday.